Profound Medical Corp. 8-K
Research Summary
AI-generated summary
Profound Medical Corp. Announces Quarterly Results for March 31, 2026
What Happened
Profound Medical Corp. (PROF) filed a Form 8‑K on May 7, 2026 (Item 2.02) to announce its financial results for the quarter ended March 31, 2026 and to provide a business update. The company furnished a press release dated May 7, 2026 as Exhibit 99.1 to the 8‑K. The filing was signed by Chief Financial Officer Rashed Dewan.
Key Details
- Filing date: May 7, 2026 (Form 8‑K, Item 2.02).
- Reporting period: Quarter ended March 31, 2026.
- Press release detailing the quarterly results and business update furnished as Exhibit 99.1.
- 8‑K signed by Rashed Dewan, Chief Financial Officer.
Why It Matters
This 8‑K notifies investors that Profound Medical has publicly released its latest quarterly earnings and operational update. Investors should read the attached press release (Exhibit 99.1) and the company’s other SEC filings to review the actual earnings, revenue, cash flow, and any guidance or business developments disclosed, since the 8‑K itself furnishes the announcement rather than embedding full financial detail.
Loading document...